Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
DEUTERATED COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING CANCERS ASSOCIATED WITH ETBR ACTIVATION
Document Type and Number:
WIPO Patent Application WO/2019/140324
Kind Code:
A1
Abstract:
Disclosed herein are deuterated compounds, pharmaceutical compositions thereof, and methods for treating ETBR-related cancers. Also disclosed herein is a delivery system for the controlled, systemic release of at least one deuterated ETBR antagonist, optionally in conjunction with an additional anti-oncologic agent.

More Like This:
WO20020853531,4,5,6-TETRAHYDROPYRAZOLO-[3,4-C]-PYRIDIN-7-ONES AS FACTOR XA INHIBITORS
JP20135281722-Phenylbenzoylamide
WO/2019/149657BENZYL-, (PYRIDIN-3-YL)METHYL- OR (PYRIDIN-4-YL)METHYL-SUBSTITUTED OXADIAZOLOPYRIDINE DERIVATIVES AS GHRELIN O-ACYL TRANSFERASE (GOAT) INHIBITORS
Inventors:
JAMAL SUMAYAH (US)
Application Number:
PCT/US2019/013377
Publication Date:
July 18, 2019
Filing Date:
January 11, 2019
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
ENB THERAPEUTICS INC (US)
International Classes:
A61K31/437; A61K31/506; A61K38/16
Domestic Patent References:
WO2017165491A12017-09-28
Foreign References:
US20170035836A12017-02-09
Other References:
See also references of EP 3713571A4
Attorney, Agent or Firm:
MATA, David G. (US)
Download PDF:
View/Download PDF      PDF Help



 
Previous Patent: ENCAPSULATED CANNABINOID FORMULATIONS FOR ORAL DELIVERY

Next Patent: ENCAPSULATED CANNABINOID FORMULATIONS FOR INHALATION OR INJECTION